About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Philadelphia | 17,601 Studies Near You

Clinical TrialsPhiladelphia

Clinical Trials in Philadelphia

Discover 17,601 clinical trials near Philadelphia, Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 2121-2140 of 17,601 trials

TerminatedTrial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent SurgeryProspective, open-label clinical trial to evaluate the efficacy and safety of andexanet alfa patients who require urgent surgery that have been anticoagulated with the FXa…NCT04233073·Phoenix, Arizona and 55 others

Find Trials by Condition in Philadelphia

Breast Cancerin Philadelphia Lung Cancerin Philadelphia Prostate Cancerin Philadelphia Colorectal Cancerin Philadelphia Melanomain Philadelphia Leukemiain Philadelphia Lymphomain Philadelphia Pancreatic Cancerin Philadelphia Ovarian Cancerin Philadelphia Brain Cancerin Philadelphia

Data from ClinicalTrials.govTerms

CompletedDose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic EsophagitisThis is a randomized, placebo-controlled, parallel-arm, dose-ranging study in subjects with eosinophilic esophagitis, 2-18 years of age.NCT00762073·Phoenix, Arizona and 19 others

CompletedC-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate CancerPatients with castrate resistant prostate cancer (CRPCA) with osseous metastatic disease planning to undergo Ra-223 therapy may be eligible for this study.NCT02715583·Philadelphia, Pennsylvania

Active not recruitingGenetic Testing in Guiding Treatment for Patients With Brain MetastasesThis phase II trial studies how well genetic testing works in guiding treatment for patients with solid tumors that have spread to the brain.NCT03994796·Anchorage, Alaska and 434 others

CompletedPeroral Endoscopic Myotomy (POEM) for Esophageal MotilityThe investigators wish to monitor the adoption of a new, incisionless approach to performing a Heller myotomy for the surgical treatment of achalasia.NCT02314741·Philadelphia, Pennsylvania

RecruitingNANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) TrialThis is a phase II study looking at patient response to treatment with the combination dinutuximab, temozolomide, irinotecan, and GM-CSF.NCT06450041·Los Angeles, California and 12 others

CompletedA Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced Interbody Cages in the Lumbar SpineThe purpose of this trial is to collect clinical outcomes including radiographic and CT outcomes in patients who undergo interbody spinal fusion using the EVOS Lumbar Interbody…NCT03928041·Charlotte, North Carolina and 1 other

CompletedTai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint TrialThis trial studies new methods using Tai Chi for the relief of joint pain (arthralgia) caused by an aromatase inhibitor in patients with stage I-III breast cancer.NCT04716920·Philadelphia, Pennsylvania

CompletedStudy to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)To determine the efficacy, long-term safety, and tolerability of alirocumab 300 mg every 4 weeks (Q4W), in comparison with placebo, as well as its potential as a starting regimen.NCT01926782·Chandler, Arizona and 82 others

TerminatedThe ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 DeficiencyThe primary purpose of Study INZ701-104 (the ENERGY study) is to assess the safety and tolerability of INZ-701 in infants with ENPP1 Deficiency or with ABCC6 Deficiency.NCT05734196·San Diego, California and 4 others

RecruitingmyAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the HomeParallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care…NCT05204888·Birmingham, Alabama and 26 others

CompletedBioavailability of LY03004 and Risperdal® Consta®This study is to assess the bioavailability of LY03004 compared to Risperdal Consta as well as the evaluate the safety and tolerability and preliminary efficacy of LY03004 with…NCT02091388·Little Rock, Arkansas and 9 others

Active not recruitingStudy of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and People at Increased Risk of Severe COVID-19The purpose of this study is to evaluate the safety and immunogenicity of a single dose of Sanofi's Omicron subvariant-based Nuvaxovid in participants ≥ 65 years of age and…NCT07861542·Fair Oaks, California and 19 others

TerminatedCelecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RTRATIONALE: Celecoxib may stop the growth of tumor cells by blocking the enzymes necessary for their growth.NCT00068770·Tampa, Florida and 6 others

TerminatedNeoadjuvant Colorectal Cancer With Unresectable Liver MetastasesThe study was terminated early due to low enrollment with only 2 subjects enrolled and treated after being open for enrollment for over a year.NCT00106054·New York, New York and 1 other

CompletedEfficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAEThis is a phase 3, multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of DX-2930 in preventing acute angioedema attacks in…NCT02586805·Birmingham, Alabama and 40 others

CompletedA Study of Strategies for Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial FibrillationThis is a study of different techniques for treatment of atrial fibrillation using a procedure called radiofrequency catheter ablation.NCT00434694·Philadelphia, Pennsylvania and 1 other

RecruitingSocial Groups for Autistic Young Adults (SDARIYA)This is a clinical trial that will test whether a group program called SDARI (Socio-dramatic Affective Relational Intervention) can help autistic young adults between the ages of…NCT07222982·Philadelphia, Pennsylvania

Active not recruitingExemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticThis randomized phase III trial studies exemestane and entinostat to see how well they work compared to exemestane alone in treating patients with hormone receptor-positive breast…NCT02115282·Birmingham, Alabama and 652 others

CompletedUltrasound Assessment of Ventral Hernia DefectsQuantitative radiographic imaging holds promise as a novel and innovative strategy to assess ventral hernia patients.NCT03043079·Philadelphia, Pennsylvania

PreviousPage 107 of 881Next

Diabetes

in Philadelphia

Heart Diseasein Philadelphia